Rocuronium Fresenius rocuronium bromide 50mg/5mL solution for injection vial

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

rocuronium bromide, Quantity: 10 g/L

Disponible des:

Fresenius Kabi Australia Pty Ltd

Designació comuna internacional (DCI):

Rocuronium bromide

formulario farmacéutico:

Injection, solution

Composición:

Excipient Ingredients: water for injections; glacial acetic acid; sodium acetate trihydrate; sodium chloride

Vía de administración:

Intravenous

Unidades en paquete:

10 x 5mL, 5 x 5mL

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

INDICATIONS,Rocuronium is indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, children and infants over 1 month of age.,Rocuronium is also indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated, however, this has not been studied in infants and children.,Rocuronium is also indicated as an adjunct in the intensive care unit (ICU) to facilitate mechanical ventilation.

Resumen del producto:

Visual Identification: A clear, colourless to pale brownish-yellow solution.; Container Type: Vial; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius

Estat d'Autorització:

Licence status A

Data d'autorització:

2014-11-12